Education

Watch “Gene Therapy: Yesterday, Today, and Tomorrow” from ASGCT and NORD

ASGCT Staff - September 24, 2019

“Gene Therapy: Yesterday, Today, and Tomorrow,” the first of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available for free.

“Gene Therapy: Yesterday, Today, and Tomorrow,” the first of five educational webinars from ASGCT and the National Organization for Rare Disorders (NORD), is now available for free.

You can watch the recording of the first webinar, “Gene Therapy: Yesterday, Today and Tomorrow,” which provides an overview of the world of gene therapy. This free session, directed towards patients and the public, offers clear and simple explanations of the field’s history, the benefits and challenges of gene therapy, along with future trends. Live webinar attendees had the opportunity to ask questions before and after the webinar to presenters, Phillip Tai, Ph.D., and Cenk Sumen, Ph.D., the current and former chairs, respectively, of the ASGCT Outreach and Communications Committee. The slides are available for viewing and downloading below.

Join us for the second webinar, “The Science Behind Gene Therapy,” September 25, at 3 p.m. (ET). In addition, mark your calendar for the rest of this free webinar series. They are all designed to inform patients, patient advocates, families, and the public about various aspects of gene therapy.

  • The FDA’s Role in Gene Therapy – Wednesday, October 30
  • Understanding the Gene Therapy Process and Aftercare – Wednesday, November 20
  • Life After Gene Therapy – Wednesday, December 18

Download the full slide deck PDF

 

Share This Page

Related Articles

Education

Watch “The FDA's Role in Gene Therapy,” from ASGCT and NORD

ASGCT Staff - November 15, 2019
Education

Learn About Gene Therapy for Hemophilia

ASGCT Staff - November 12, 2019
Education

How Can Gene Therapy Help MPS Patients?

ASGCT Staff - October 29, 2019
Education

Learn About Gene Therapy for Huntington’s Disease

ASGCT Staff - October 15, 2019